Mana.bio is a company that combines advanced technologies in biology and medicine. The company focuses on drug delivery, machine learning, and software development.

Mana.bio

Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.



We're proud to announce that Mana has been accepted into the #NVIDIAInception program. 

We are honored to be part of a group of startups driving changes in #AI across industries and around the world. 
This program will provide us with several opportunities, including access to NVIDIA's latest technological resources and the chance to connect with peers who are working through similar challenges. 

This is yet another exciting milestone for us as we continue to grow and work to find improved RNA delivery options.

Our CEO Yogev Debbi recently published his thoughts on the importance of speaking the language of AI in Pharma and why the future of human health depends on it.

Dig into why the industry needs to do more engineering and less gambling when it comes to drug development and how to best re-frame the way lab work is measured in order to best embrace AI. 

See the full piece below

#pharma #AI #lab #data

💊 𝗡𝗮𝗻𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆-𝗯𝗮𝘀𝗲𝗱 𝗗𝗿𝘂𝗴 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀: 𝟱 𝗦𝘁𝗮𝗿𝘁𝘂𝗽𝘀 𝘁𝗼 𝗪𝗮𝘁𝗰𝗵! 👀 

🔵 The growing use of nanotechnology in drug delivery is transforming healthcare by allowing for targeted, efficient, and controlled release of medications!

🔵 These young companies are great examples of startups leading the way in this transformation, developing state-of-the-art technologies that improve the precision and effectiveness of treatments!

🔵 From targeted cancer treatments to advanced gene therapies, these startups are laying the groundwork for a new era in medicine!

🔵 Take a look through the startups in our list:
💠 Aera Therapeutics
💠 Orion Therapeutics, Inc.
💠 NanoPhoria
💠 NanoVation Therapeutics™
💠 Mana.bio
----------------------------------------------
What startups can you add to the list?


Source: VentureRadar
#startup #drugdelivery #lipidnanoparticle #LNP #liposome #biotechnology #biopharmaindustry #nanotechnology

I was honored to present as a part of Biomed Israel 2024 last week discussing how to "Unlock Extra-Hepatic Delivery Using Machine Learning." Our work at Mana.bio, along with many other companies showed the potential for how #AI will continue to impact different aspects of #pharma including drug development, target discovery, diagnostics and more.

Overall the event showed just how many advancements have been made in genetic medicine therapeutics, delivery and clinical progress and it was heartening to see increased innovative science moving from academic research into newly functioning startups. We were thrilled to observe the potential in delivery of genetic medicine that will begin to disrupt so many therapeutic areas and we are excited to push forward as a community to leverage AI to unlock that promise.

Our CEO, Yogev Debbi will be speaking at Biomed Israel 2024 this week on May 21st 3-5pm local time. If you're registered, please consider attending and be sure to say hello.

We are excited to sponsor a Workshop at the Controlled Release Society conference this morning on The Application of AI to Drug Delivery. Co-sponsored with METiS Therapeutics and organized by Daniel Heller and Avi Schroeder, in the beautiful Bologna, Italy. Come and listen to so many terrific experts in this area.

#AI 
#drugdelivery
#LNP
#data

BIO:MANA

Mana.bio

name

homepage url

country

linkedin url

employee count

sector

industry

monthly webtraffic

monthly webtraffic growth

stage

raised capital

Description

investor of

Metrics